FINANCIAL RESULTS FOR THE QUARTER

ENDED MARCH 31 , 2005

GLAXOSMITHKLINE CONSUMERGLAXOSMITHKLINE CONSUMERHEALTHCARE LIMITEDHEALTHCARE LIMITED

(RS. LAKHS)

GLAXOSMITHKLINE CONSUMER HEALTHCARE LIMITEDUNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2005

ACCOUNTING YEARDEC 31, 2004

PARTICULARS 31-Mar-05 31-Mar-04 (AUDITED)Gross Sales 25431 23736 98172Less : Excise Duty 3128 2932 11955Net Sales 22303 20804 86217Other Income 596 639 2549

Total Revenues 22899 21443 88766Expenditure:a) (Increase)/Decrease in Stock in Trade (348) (10) 645b) Consumption of Raw/Packing Materials 7662 7562 29764c) Purchase of Finished Goods 99 215 809d) Cost of Goods Sold (a+b+c) 7413 7767 31218e) Staff Cost (Net) 2767 2181 10063f) Advertising & Promotion 2668 2040 10145g) Other Expenses 5163 5223 20609

Total Expenditure (d+e+f+g) 18011 17211 72035Operating Profit Before Interest, Depreciation, Amortisation,Taxation 4888 4232 16731Interest 102 94 525Depreciation 912 891 3686

Profit Before Amortisation, Taxation 3874 3247 12520Amortisation of:- Patents and Trade Marks (Depreciation) 115 115 461- Deferred Revenue Expenditure 0 123 491

Profit Before Taxation 3759 3009 11568Provision for Taxation - Current Charge 1047 842 3870- Deferred Tax 75 216 382

Profit After Taxation 2637 1951 7316-Paid Up Equity Share Capital 4538 4538 4538-Face Value of Equity Shares-Rs. 10 10 10-Reserves Excluding Revaluation Reserves 48397 -Aggregate of Non -Promoter Shareholding -Number of Shares 27228378 27228378 27228378 -Percentage of Shareholding 60 60 60

Basic and Diluted EPS- ( Not Annualised for the Quarter) (Rs.) 5.81 4.30 16.12

Interim Dividend Per Share- (Rs.) - - 7.00

Quarter Ended

GLAXOSMITHKLINE CONSUMER HEALTHCARE LIMITEDUNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2005

NOTES

(1)The Company is focussed in the business of Nutritional Healthcare in India. Therefore, there is no reportable segment as per the provisions of Accounting Standard 17 on “Segment Reporting” issued by the Institute of Chartered Accountants of India.

(2) There were no pending investor complaints at the beginning of the quarter. The Company received 151 complaints during the quarter. 133 complaints were disposed off and balance 18 complaints were pending at the end of the quarter which has since been resolved.

(3) The board of directors, of the Company at their meeting held on December 10, 2004, proposed a buy-back of fully paid equity shares of a face value of Rs.10 each at a price not exceeding Rs. 370 per equity share and for an amount not exceeding Rs.12302.81 lakhs in accordance with the provisions of the Companies Act,1956 and Securities and Exchange Board of India (Buy Back of Securities) Regulations, 1998 which was subsequently approved through Postal Ballot by the shareholders. The offer was closed on 12 April, 2005 which was oversubscribed by 135%.The same does not have a financial impact on the profit of the Company for the quarter ended March 31, 2005.

(4) Staff Cost includes an amount of Rs.470 Lakhs towards one-time encashment of accumulated leave balances being a change in leave encashment policy for eligible management personnel.

(5) Figures of previous quarter/year have been regrouped wherever necessary, to conform to this quarter’s classification.

(6) The above results have been reviewed by the Audit Committee of the Board and approved by the Board of Directors of the company at its meeting held on April 28, 2005. The Limited Review by the Statutory Auditors , as required under Clause 41 of the Listing Agreement has been completed and the related report dated April 28, 2005 has been forwarded to the Stock Exchanges.

REGD. OFFICE:PATIALA ROAD, NABHA 147201 (PUNJAB).HEAD OFFICE:DLF PLAZA TOWER, DLF CITY PHASE I, GURGAON - 122002, HARYANA.

NABHAAPRIL 28, 2005

ON BEHALF OF THE BOARD

NICHOLAS J. MASSEY MANAGING DIRECTOR

THANK YOU